Search MLAB
MESA LABORATORIES INC /CO/
Nasdaq · CIK 724004
Last close132.55
Daily change+3.25 (2.51%)
10 Years gain+20.50%
Dividends TTM0.64 (+0.00%)
Dividend yield0.49%
Fundamental Analysis
MLAB · STANDARD
SIC 3823 · Industrial Instruments For Measurement, Display, and Control · Fiscal year end 0331
Fundamental
51.2Momentum
64.6Acceleration
66.1Confidence
91.0Annual Revenue16
Quarterly Revenue69
Annual CFO11
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth10.5 / 25
Quality20.7 / 25
Capital Efficiency4.8 / 20
Balance Sheet9.3 / 15
Shareholder Economics4.2 / 10
Forward Indicators1.7 / 5
Signals
Gross margin expansionGross margin improved by 0.3713 percentage points.
Operating leverageOperating margin improved by 2.9124 percentage points.
ROIC expansionROIC improved by 3.6678 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Strong operating leverageOperating income is growing faster than revenue while operating margin expands.
Key Metrics
Revenue Growth TTM5.69%OK
Revenue CAGR 3Y4.38%OK
Gross Margin63.16%OK
Operating Margin9.28%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC7.61%OK
Incremental Operating Margin 3Y32.42%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y6.04%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Mar 31, 2026 | $249.13M | $158.27M | $18.51M | $42.83M | $39.58M | 63.53% | 7.43% | 15.89% | 5.59% | 5.57M |
| 2026 FY Mar 31, 2025 | $240.98M | $150.87M | $16.34M | $46.81M | $42.56M | 62.61% | 6.78% | 17.66% | 6.62% | 5.42M |
| 2026 FY Mar 31, 2024 | $216.19M | $133.25M | -$272.08M | $44.13M | $41.57M | 61.64% | -125.85% | 19.23% | -89.98% | 5.39M |
| 2025 FY Mar 31, 2023 | $219.08M | $133.69M | $3.32M | $27.98M | $23.44M | 61.02% | 1.52% | 10.7% | 0.74% | 5.36M |
| 2024 FY Mar 31, 2022 | $184.34M | $109.09M | $4.70M | $39.22M | $34.79M | 59.18% | 2.55% | 18.87% | 1.26% | 5.34M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $245.54M | sum latest 4 fiscal quarters Revenue | OK | 0001437749-26-026808, 0000724004-25-000013 |
| Revenue Growth TTM | 5.69% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001437749-26-026808, 0000724004-25-000013 |
| Revenue CAGR 3Y | 4.38% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000724004-26-000047 |
| Revenue CAGR 5Y | 13.22% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000724004-26-000047 |
| Gross Profit CAGR 3Y | 5.79% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000724004-26-000047 |
| Operating Income Growth | 54.01% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001437749-26-026808, 0000724004-25-000013 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 63.16% | Gross Profit / Revenue | OK | 0001437749-26-026808, 0000724004-25-000013 |
| Operating Margin | 9.28% | Operating Income / Revenue | OK | 0001437749-26-026808, 0000724004-25-000013 |
| ROIC | 7.61% | NOPAT / Average Invested Capital | OK | 0001437749-26-026808, 0000724004-25-000013 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001437749-26-026808 |
| Current Ratio | 1.79x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 0.46x | (Cash + Short-term Investments) / Total Debt | OK | 0001437749-26-026808 |
| Revenue per Diluted Share | $42.65 | Revenue / Diluted Shares | OK | 0001437749-26-026808, 0000724004-25-000013 |